Natera, Inc. (NASDAQ:NTRA) was downgraded by research analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a research report issued on Monday, July 24th.
NTRA has been the topic of a number of other reports. Zacks Investment Research lowered shares of Natera from a “buy” rating to a “hold” rating in a research note on Thursday, May 11th. Canaccord Genuity lifted their target price on shares of Natera from $14.00 to $16.00 and gave the company a “buy” rating in a report on Wednesday, May 10th. Four equities research analysts have rated the stock with a sell rating and four have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $14.45.
Natera (NASDAQ NTRA) traded up 5.04% on Monday, reaching $10.62. The company’s stock had a trading volume of 278,269 shares. Natera has a one year low of $7.35 and a one year high of $12.95. The company’s market capitalization is $565.23 million. The firm has a 50-day moving average of $9.97 and a 200-day moving average of $9.55.
Natera (NASDAQ:NTRA) last posted its quarterly earnings data on Tuesday, August 8th. The medical research company reported ($0.52) EPS for the quarter, meeting analysts’ consensus estimates of ($0.52). The company had revenue of $53.60 million for the quarter, compared to analyst estimates of $50.57 million. Natera had a negative net margin of 62.64% and a negative return on equity of 137.46%. Natera’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the business posted ($0.46) earnings per share. Analysts predict that Natera will post ($2.08) EPS for the current year.
Institutional investors have recently made changes to their positions in the company. GSA Capital Partners LLP purchased a new position in Natera during the fourth quarter worth $121,000. Russell Investments Group Ltd. purchased a new position in Natera during the fourth quarter worth $130,000. Virtu KCG Holdings LLC purchased a new position in Natera during the second quarter worth $126,000. Los Angeles Capital Management & Equity Research Inc. purchased a new position in Natera during the second quarter worth $151,000. Finally, American International Group Inc. raised its position in shares of Natera by 7.1% in the first quarter. American International Group Inc. now owns 16,065 shares of the medical research company’s stock valued at $142,000 after buying an additional 1,068 shares during the period. Institutional investors own 59.74% of the company’s stock.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Natera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.